New Milford, CT, United States of America

Sabine K Schlyer

USPTO Granted Patents = 8 


 

Average Co-Inventor Count = 7.7

ph-index = 2

Forward Citations = 46(Granted Patents)


Company Filing History:


Years Active: 2012-2020

Loading Chart...
Loading Chart...
Loading Chart...
8 patents (USPTO):

Title: The Innovative Contributions of Sabine K Schlyer

Introduction

Sabine K Schlyer is a prominent inventor based in New Milford, CT, known for her significant contributions to the field of pharmaceuticals. With a total of eight patents to her name, she has made remarkable strides in developing novel compounds that address various medical conditions.

Latest Patents

Among her latest patents are Rho kinase inhibitors, which disclose novel substituted 2H-isoquinolin-1-one and 3H-quinazolin-4-one derivatives. These compounds are useful as inhibitors of Rho kinase and are aimed at treating a variety of diseases and disorders mediated by Rho kinase activity, including cardiovascular diseases. Additionally, her patent on soluble guanylate cyclase activators relates to specific compounds and their pharmaceutical compositions, methods of use, and processes for preparation.

Career Highlights

Sabine has worked with notable companies such as Boehringer Ingelheim International GmbH and Aerie Pharmaceuticals, Inc. Her work in these organizations has allowed her to contribute to the advancement of pharmaceutical research and development.

Collaborations

Throughout her career, Sabine has collaborated with esteemed colleagues, including John David Ginn and Anthony S Prokopowicz. These partnerships have further enhanced her innovative efforts in the pharmaceutical industry.

Conclusion

Sabine K Schlyer exemplifies the spirit of innovation in the pharmaceutical field through her patents and collaborations. Her work continues to impact the treatment of various diseases, showcasing her dedication to advancing medical science.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…